COYA
Price
$6.15
Change
-$0.25 (-3.91%)
Updated
Jul 31, 01:15 PM (EDT)
Capitalization
97.76M
12 days until earnings call
EYPT
Price
$10.04
Change
+$0.19 (+1.93%)
Updated
Jul 31, 02:00 PM (EDT)
Capitalization
677.11M
6 days until earnings call
Interact to see
Advertisement

COYA vs EYPT

Header iconCOYA vs EYPT Comparison
Open Charts COYA vs EYPTBanner chart's image
Coya Therapeutics
Price$6.15
Change-$0.25 (-3.91%)
Volume$2K
Capitalization97.76M
EyePoint Pharmaceuticals
Price$10.04
Change+$0.19 (+1.93%)
Volume$100
Capitalization677.11M
COYA vs EYPT Comparison Chart in %
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. EYPT commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (COYA: $5.84 vs. EYPT: $9.84)
Brand notoriety: COYA and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 155% vs. EYPT: 61%
Market capitalization -- COYA: $97.76M vs. EYPT: $677.11M
COYA [@Biotechnology] is valued at $97.76M. EYPT’s [@Biotechnology] market capitalization is $677.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $239.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 6 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 6 bullish, 4 bearish.
  • EYPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COYA is a better buy in the short-term than EYPT.

Price Growth

COYA (@Biotechnology) experienced а +2.72% price change this week, while EYPT (@Biotechnology) price change was -8.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +19.61%, and the average quarterly price growth was +44.86%.

Reported Earning Dates

COYA is expected to report earnings on Aug 12, 2025.

EYPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($677M) has a higher market cap than COYA($97.8M). EYPT YTD gains are higher at: 32.081 vs. COYA (2.007). COYA has higher annual earnings (EBITDA): -19.42M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. COYA (35.5M). EYPT has higher revenues than COYA: EYPT (56M) vs COYA (3.69M).
COYAEYPTCOYA / EYPT
Capitalization97.8M677M14%
EBITDA-19.42M-144.55M13%
Gain YTD2.00732.0816%
P/E RatioN/AN/A-
Revenue3.69M56M7%
Total Cash35.5M318M11%
Total DebtN/A24.1M-
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYAEYPT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 14 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BXBLY30.750.51
+1.69%
Brambles, Ltd.
BPZZF14.01N/A
N/A
Boston Pizza Royalties Income Fund
PNGZF0.03N/A
N/A
Terra Metals Ltd
SFFFF71.94N/A
N/A
PEUGEOT INVEST
EBGEF24.38-0.01
-0.04%
Enbridge Inc.

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-8.67%
KNSA - COYA
42%
Loosely correlated
-1.02%
GANX - COYA
34%
Loosely correlated
-4.46%
XNCR - COYA
32%
Poorly correlated
-1.02%
NTLA - COYA
32%
Poorly correlated
-1.36%
EYPT - COYA
32%
Poorly correlated
-0.10%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-0.10%
OCUL - EYPT
59%
Loosely correlated
-0.77%
LYRA - EYPT
58%
Loosely correlated
-10.64%
RXRX - EYPT
54%
Loosely correlated
-2.35%
ATHE - EYPT
54%
Loosely correlated
-3.18%
BEAM - EYPT
53%
Loosely correlated
+1.10%
More